Blogterview with Fight Aging!’s Reason: answers to life extension questions

Our first answerer to the 6 questions is Reason, who is the main driving force of the biggest and most established life extension site, Fight Aging! (Technorati Rank) and The Longevity Meme, continuously from 2001. 1. What is the story of your life extension commitment? I don’t like the idea of decaying, suffering and dying.… Continue reading Blogterview with Fight Aging!’s Reason: answers to life extension questions

5 simple questions to life extension supporters, 1 plus for bloggers

My plan is to make short interviews using the same 6 questions with today’s life extension supporters/bloggers around the blogosphere. The first answerer will be Reason, the engine behind Fight Aging! and Longevity Meme. Here are the questions: 1. What is the story of your life extension commitment? 2. Is it a commitment for moderate… Continue reading 5 simple questions to life extension supporters, 1 plus for bloggers

New lingo: Stells in RegMed and TEg

Here at the beautiful Costa Brava in the Stem Cells in Tissue Engineering Conference we hear the terms stem cells, tissue engineering, regenerative medicine so many times, so here I am pleased to offer some abbreviations, which are the results of a yesterday late night beer brainstorming: Stem cells: Stells, Tissue Engineering: TEg, Regenerative Medicine:… Continue reading New lingo: Stells in RegMed and TEg

Stem Cells in Tissue Engineering Conference: Blog and Wiki

As I’ve mentioned before from tomorrow I will be at Sant Feliu de Guixols, Spain, at the Conference Stem Cells in Tissue Engineering, 28.10-2.11,2006 organized by the European Science Foundation. The official website of the conference is: http://www.esf.org/conferences/lc06213 In the IT sector it is more and more natural that a Conference has a wiki and… Continue reading Stem Cells in Tissue Engineering Conference: Blog and Wiki

What would happen if Bill Gates invested 3 billion dollars to embryonic stem cell research?

There is a dense comment debate on Bodyhack for more than a week concerning the electoral Missouri Stem Cell Hunter issue, celebs with ESC pro- or contra ads. Here is an effective comment from today’s related post by the commenter named Orrin: “I wonder what would happen if Bill Gates invested 2 billion dollars to… Continue reading What would happen if Bill Gates invested 3 billion dollars to embryonic stem cell research?

3 free articles in the November Issue of Tissue Engineering

Thanks to a new rapid publication policy you can download now 3 excellent articles from the November Issue of Tissue Engineering published by Mary Ann Liebert, Inc.: Ex Vivo Engineering of Living Tissues with Adult Stem Cells by Bonnie Barrilleaux, B.S., Donald G. Phinney, Darwin J. Prockop, and Kim O Connor. This is maybe the… Continue reading 3 free articles in the November Issue of Tissue Engineering

Stem Cells get viral and part of the pop culture: The Stem Cells – live

The term ‘Stem Cells’ eventually stepped out its scientific home and became the viral name of a music-performance group. Hear their Human Stem Cell Audio Therapy blabla from their website transmitted to audio by me via Odeo: [odeo=http://odeo.com/audio/2234526/view] Anyway, I offer the next music names for future generations: Tissue Engineers, DJ RegMed, MC Growth Factor,… Continue reading Stem Cells get viral and part of the pop culture: The Stem Cells – live

New England All-Stars Award goes to Advanced Cell’s Lanza

Dr. Robert Lanza, vice president of Research and Scientific Development for Worcester-based Advanced Cell Technology (ACT), will be honored at the 11th annual Mass High Tech All-Stars Awards Networking Reception on Wednesday at the category biotechnology. Link Lanza is a key person in American human embryonic stem cell technology. Some public rearguard actions of the… Continue reading New England All-Stars Award goes to Advanced Cell’s Lanza

First full-time biotech employee at Google BioLabs

Hello everybody, let me introduce myself: I am the first full-time biotechnologist at Google Inc. (well, not really). My job at Google is fascinating: I have to plan and build a comprehensive regenerative database/map of the complete human body which will be the input of the ultimate human regenerative software. It is so, because in… Continue reading First full-time biotech employee at Google BioLabs

Brutal competition in stem cell research: Harvard fears

At 13th, October, a daylong event, the Stem Cell Leadership Summit Friday was organized by AAAS in Cambridge, US. Some quotes worth mentioning: The controversial Lawrence H. Summers, former Harvard president: “we are not alone in seeing the enormous impact biomedical research in general, and stem cell science in particular, will have on the region… Continue reading Brutal competition in stem cell research: Harvard fears

Early science protocol video: OpenWetWare Drosophila CHiP

One previous post of Pimm was about the advantages of online, open source-like science protocol videos. So thanks to Sri Kosuri, here is an early sample protocol movie (3 parts) made by John Cumbers on the preparation of fixed chromatin from Drosophila embryos to use the DNA in a genomic array technology, developed in Rob… Continue reading Early science protocol video: OpenWetWare Drosophila CHiP

FDA Stem Cell Therapy Regulation: the Framework

Dina Gould Halme and David A. Kessler wrote an article, called FDA Regulation of Stem-Cell–Based Therapies in The New England Journal of Medicine. The key concerns are: i., Stem-cell–based products as therapeutic agents are or could be: biologic products, drugs, devices, xenotransplantation products, human cells, tissues, and cellular and tissue-based products. Human cells, tissues, and… Continue reading FDA Stem Cell Therapy Regulation: the Framework

Science: video protocols can help to share the tacit dimension

Matias Pasquali has a short piece in recent Nature Magazine on the upcoming role of DIY videos in protocol sharing between scientists: “Probably the most feasible approach is to publish movies describing the methods, a service already offered by some publications and protocol websites, but which could become routine. Much more information on the essential… Continue reading Science: video protocols can help to share the tacit dimension

Financial update to stem cell patent debate: California vs Wisconsin?

The story of the first human embryonic stem cell’s patent (isolated by Thomson) at Wisconsin Alumni Research Foundation (WARF) continues. The amount of money behind stem cell patens became visible thanks to David Wahlberg’s exploration in today’s Wisconsin State Journal: The stem-cell patents have brought $3.2 million in license fees to WARF. About 75 percent… Continue reading Financial update to stem cell patent debate: California vs Wisconsin?

Stem Cells’ growing role in U.S. politics: StemCandidates meet Pacman

John Hlinko, veteran internet grass-roots organizer has launched a website called StemCellCandidates to highlight — and facilitate donations for — the races in which the stem cell issue is most likely to tip the scales. Hlinko is also the man behind StemPac, a U.S. stem cell research supporting coaliton, which includes professional political consultants, scientists… Continue reading Stem Cells’ growing role in U.S. politics: StemCandidates meet Pacman

Stem Cells in Tissue Engineering: Conference in Sant Feliu de Guixols, Spain

I have a chance to participate with a poster at an upcoming conference on Stem Cells in Tissue Engineering – Isolation, Culture, Characterisation and Applications in Sant Feliu de Guixols, Spain, 28.10-02.11. Here are some lectures from the programme, which I’d like to visit by all means (my comments in italics): 29.10. Sunday 11.45-12.35 J.… Continue reading Stem Cells in Tissue Engineering: Conference in Sant Feliu de Guixols, Spain

Yet another industrial stem cell alliance: Aldagen meets IMT

From PharmaLive: Aldagen, Inc. and Innovative Micro Technology (IMT) today announced that they have formed an alliance to co-develop and commercialize a version of IMT’s Rare Cell Purification System, customized specifically for clinical cell therapies. This system, called the ALDESORTER(TM), will be used with Aldagen’s ALDESORT(R) product and is designed to isolate unique stem cell… Continue reading Yet another industrial stem cell alliance: Aldagen meets IMT

Non-profit trial to speed up embryonic stem cell research through patent narrowing

From The Scientist by Cathy Tran: At the request of a coalition of non-profit groups, which was initiated by groups in California, a state that has a lot at stake as a result Proposition 71, the U.S. Patent and Trademark Office (PTO) is reexamining patents covering all primate embryonic stem cells, as well as stem-cell… Continue reading Non-profit trial to speed up embryonic stem cell research through patent narrowing

$2.9 million NIH Quantum Grant for Neuro-Vascular Regeneration to help stroke patients

For the first time Quantum Grant goes for international research initiative to regenerate damaged brain cells and blood vessels for the treatment of stroke which occurs when an artery in the brain is blocked. The three-year, $2.9 million grant, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the NIH, will… Continue reading $2.9 million NIH Quantum Grant for Neuro-Vascular Regeneration to help stroke patients

Bodies in the Making book, essays by UC Santa Cruz professors

A new book coedited by UC Santa Cruz Literature and Anthropology professors Helene Moglen and Nancy Chen, Bodies in the Making: Transgressions and Transformations, explores a range of practices that aren’t usually linked: tattooing, cosmetic surgery, body-building, life extension technologies, self-cutting. The common denominator is intended to be body hacking, modification and our fascination with… Continue reading Bodies in the Making book, essays by UC Santa Cruz professors

Weekend joke: Pimm Regeneration search engine

The web is usually dead at the weekends, but here is a brand new service from bioGoog: just type the name and last regeneration date of your tissue and organ into the stomach of the Pimm search engine and you will see which local clinic accepted your request and when for next regeneration. 🙂 Link:… Continue reading Weekend joke: Pimm Regeneration search engine

Stem Cell Career Prospects: Multiple Potentials

Today’s ScienceCareers.org has a comprehensive and enthusiastic ad section considering Careers in Stem Cell Research: Rejuvenating Biology and Medicine by Mike May: Beth Donley, executive director of the WiCell Research Institute at the University of Wisconsin, Madison says ”For stem cells, the breadth of application will depend largely on the extent of the scientific imagination.”… Continue reading Stem Cell Career Prospects: Multiple Potentials

Factors to consider before saying YES to the extension of life

A study at the University of Queensland, Australia examined community attitudes to the extension of life headed by project Research Manager Dr Mair Underwood (left): Dr Underwood said the most important consideration was quality of life as participants did not want to spend their extra years in a nursing home. But study participants also mentioned… Continue reading Factors to consider before saying YES to the extension of life

Coating heart stents with human stem cells.

A stent is a small metal coil, slotted tube, or mesh structure that is placed in a coronary artery to keep it open and wide allowing more blood through. It is a permanent implant and the most common intervention for Coronary Artery Disease. From Yorkshire Post Today: Scientists from Sheffield University are developing the world’s… Continue reading Coating heart stents with human stem cells.

MIT Tech Review Editor on biotech’s rising star

Jason Pontin, editor-in-chief and publisher of MIT’s Technology Review Magazine who was speaking last week, at MIT’s Emerging Technologies Conference had the opinion in a discussion, that “It’s probably fair to say there’s more revolutionary innovation occuring in biotech and in the material sciences (nanotech) than there is in IT at the moment.” Link It… Continue reading MIT Tech Review Editor on biotech’s rising star

U.S. stem cell companies: a new roundup

From Investor’s Business Daily: Big pharmaceutical firms and major biotechs are holding back as well, William Caldwell CEO of Advanced Cell Technology says. “While all of them have stem cell development labs someplace in the bowels of their organizations, they are not putting capital into the sector.” These companies are nervous about the political and… Continue reading U.S. stem cell companies: a new roundup